Cargando…
Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606607/ https://www.ncbi.nlm.nih.gov/pubmed/36313997 http://dx.doi.org/10.3389/fmed.2022.940454 |
_version_ | 1784818333617487872 |
---|---|
author | Kazemifard, Nesa Dehkohneh, Abolfazl Baradaran Ghavami, Shaghayegh |
author_facet | Kazemifard, Nesa Dehkohneh, Abolfazl Baradaran Ghavami, Shaghayegh |
author_sort | Kazemifard, Nesa |
collection | PubMed |
description | Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gut microbiota. Cross-talks between gut bacteria and the host immune system are initiated at birth during microbial colonization and directly control the immune responses and protection against pathogen colonization. Imbalances in the gut microbiota composition, termed dysbiosis, can trigger several immune disorders through the activity of the adaptive immune system and impair the adequate response to the vaccination. The bacteria used in probiotics are often members of the gut microbiota, which have health benefits for the host. Probiotics are generally consumed as a component of fermented foods, affect both innate and acquired immune systems, and decrease infections. This review aimed to discuss the gut microbiota's role in regulating immune responses to vaccination and how probiotics can help induce immune responses against pathogens. Finally, probiotic-based oral vaccines and their efficacy have been discussed. |
format | Online Article Text |
id | pubmed-9606607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96066072022-10-28 Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy Kazemifard, Nesa Dehkohneh, Abolfazl Baradaran Ghavami, Shaghayegh Front Med (Lausanne) Medicine Vaccination is defined as the stimulation and development of the adaptive immune system by administering specific antigens. Vaccines' efficacy, in inducing immunity, varies in different societies due to economic, social, and biological conditions. One of the influential biological factors is gut microbiota. Cross-talks between gut bacteria and the host immune system are initiated at birth during microbial colonization and directly control the immune responses and protection against pathogen colonization. Imbalances in the gut microbiota composition, termed dysbiosis, can trigger several immune disorders through the activity of the adaptive immune system and impair the adequate response to the vaccination. The bacteria used in probiotics are often members of the gut microbiota, which have health benefits for the host. Probiotics are generally consumed as a component of fermented foods, affect both innate and acquired immune systems, and decrease infections. This review aimed to discuss the gut microbiota's role in regulating immune responses to vaccination and how probiotics can help induce immune responses against pathogens. Finally, probiotic-based oral vaccines and their efficacy have been discussed. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606607/ /pubmed/36313997 http://dx.doi.org/10.3389/fmed.2022.940454 Text en Copyright © 2022 Kazemifard, Dehkohneh and Baradaran Ghavami. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Kazemifard, Nesa Dehkohneh, Abolfazl Baradaran Ghavami, Shaghayegh Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title | Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title_full | Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title_fullStr | Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title_full_unstemmed | Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title_short | Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy |
title_sort | probiotics and probiotic-based vaccines: a novel approach for improving vaccine efficacy |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606607/ https://www.ncbi.nlm.nih.gov/pubmed/36313997 http://dx.doi.org/10.3389/fmed.2022.940454 |
work_keys_str_mv | AT kazemifardnesa probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy AT dehkohnehabolfazl probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy AT baradaranghavamishaghayegh probioticsandprobioticbasedvaccinesanovelapproachforimprovingvaccineefficacy |